I'm liking this more and more - very focused on commercialisation. Good to see the BoD bringing in relevant expertise for the next stage.
Dr Kim provides services through several consultancies, but they're all involved in getting pharmaceuticals to market, licensing deals, partnering, etc.
https://www.spiegare.com.au/kim-agnew-2/
https://www.spiegare.com.au/services/
Moving forward...
I'm liking this more and more - very focused on...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |